Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cholinergic Receptors: Nicotinic01:15

Cholinergic Receptors: Nicotinic

4.9K
Nicotinic receptors are ligand-gated ion channels that are activated by acetylcholine and nicotine. Upon activation, they cause a rapid increase in the permeability of cells to K+, Na+, and Ca2+, followed by depolarization and excitation. They are in the autonomic ganglia, skeletal neuromuscular junction, CNS, and adrenal medulla.
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
4.9K
GPCR Desensitization01:12

GPCR Desensitization

7.6K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
7.6K
Drugs Acting on Autonomic Ganglia: Stimulants01:23

Drugs Acting on Autonomic Ganglia: Stimulants

1.9K

Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
1.9K
Desensitization and Tachyphylaxis01:20

Desensitization and Tachyphylaxis

2.8K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
2.8K
Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

3.5K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
3.5K
Neurochemical Transmission: Sites of Drug Action01:26

Neurochemical Transmission: Sites of Drug Action

3.3K
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
3.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Conformational dynamics of a nicotinic receptor neurotransmitter site.

eLife·2024
Same author

CHRFAM7A diversifies human immune adaption through Ca<sup>2+</sup> signalling and actin cytoskeleton reorganization.

EBioMedicine·2024
Same author

Dynamics of receptor activation by agonists.

Biophysical journal·2024
Same author

Mechanism of hydrophobic gating in the acetylcholine receptor channel pore.

The Journal of general physiology·2023
Same author

Agonist efficiency links binding and gating in a nicotinic receptor.

eLife·2023
Same author

Agonist efficiency from concentration-response curves: Structural implications and applications.

Biophysical journal·2021
Same journal

Conformational changes upon pore blocker removal reveal conductive states of TMEM16A.

The Journal of general physiology·2026
Same journal

On the mechanism of hypomagnesemia with treatment-resistant seizures caused by variants of the Na+,K+-ATPase α1 subunit (ATP1A1).

The Journal of general physiology·2026
Same journal

Label-free real-time imaging of mitochondrial matrix volume changes and permeability transition in living cells.

The Journal of general physiology·2026
Same journal

Differential regulation of β1-dependent voltage shifts and kinetic modulation by an extracellular glutamate in NaV1.6 VSDIV.

The Journal of general physiology·2026
Same journal

Mechanistic insights into DCPIB inhibition of VRAC: Electrostatic control and binding plasticity.

The Journal of general physiology·2026
Same journal

An epilepsy-associated KV3.1 potassium channel variant acts via dominant-positive effect.

The Journal of general physiology·2026
See all related articles

Related Experiment Video

Updated: Dec 9, 2025

Local Application of Drugs to Study Nicotinic Acetylcholine Receptor Function in Mouse Brain Slices
10:04

Local Application of Drugs to Study Nicotinic Acetylcholine Receptor Function in Mouse Brain Slices

Published on: October 29, 2012

19.7K

Pathways for nicotinic receptor desensitization.

Anthony Auerbach1

  • 1Department of Physiology and Biophysics, State University of New York at Buffalo, Buffalo, NY.

The Journal of General Physiology
|September 10, 2020
PubMed
Summary
This summary is machine-generated.

Nicotinic acetylcholine receptors (AChRs) desensitize via distinct pathways depending on agonist presence. Two models, the "prism" and "monkey saddle," explain these differing desensitization and recovery pathways.

More Related Videos

Live Imaging of Nicotine Induced Calcium Signaling and Neurotransmitter Release Along Ventral Hippocampal Axons
12:19

Live Imaging of Nicotine Induced Calcium Signaling and Neurotransmitter Release Along Ventral Hippocampal Axons

Published on: June 24, 2015

9.3K
Utilizing pHluorin-tagged Receptors to Monitor Subcellular Localization and Trafficking
09:59

Utilizing pHluorin-tagged Receptors to Monitor Subcellular Localization and Trafficking

Published on: March 16, 2017

9.2K

Related Experiment Videos

Last Updated: Dec 9, 2025

Local Application of Drugs to Study Nicotinic Acetylcholine Receptor Function in Mouse Brain Slices
10:04

Local Application of Drugs to Study Nicotinic Acetylcholine Receptor Function in Mouse Brain Slices

Published on: October 29, 2012

19.7K
Live Imaging of Nicotine Induced Calcium Signaling and Neurotransmitter Release Along Ventral Hippocampal Axons
12:19

Live Imaging of Nicotine Induced Calcium Signaling and Neurotransmitter Release Along Ventral Hippocampal Axons

Published on: June 24, 2015

9.3K
Utilizing pHluorin-tagged Receptors to Monitor Subcellular Localization and Trafficking
09:59

Utilizing pHluorin-tagged Receptors to Monitor Subcellular Localization and Trafficking

Published on: March 16, 2017

9.2K

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Biophysics

Background:

  • Nicotinic acetylcholine receptors (AChRs) are ligand-gated ion channels crucial for neurotransmission.
  • AChRs exhibit desensitization, a process where channel activity diminishes despite agonist presence.
  • Understanding the distinct pathways for AChR desensitization and recovery remains a long-standing challenge.

Purpose of the Study:

  • To discuss two proposed mechanisms explaining the differential pathways of AChR desensitization and recovery.
  • To explore how ligands influence the selection between desensitization and recovery pathways.
  • To consider experimental approaches for distinguishing between the proposed mechanisms.

Main Methods:

  • Theoretical discussion of two models: a discrete-state model (prism) and a potential energy surface model (monkey saddle).
  • Analysis of kinetic and thermodynamic principles governing receptor conformational changes.
  • Consideration of ligand-specific energy properties (φ values) and transition state shifts.

Main Results:

  • The 'prism' model suggests distinct pathways due to ligand-dependent energy properties at transition states.
  • The 'monkey saddle' model proposes agonist-induced shifts in gating transition states influence pathway selection.
  • Both models indicate that desensitization pathway selection is primarily a kinetic, rather than thermodynamic, phenomenon.

Conclusions:

  • Two distinct models offer explanations for the observed differences in AChR desensitization and recovery pathways.
  • The choice of pathway appears to be governed by kinetic factors influenced by ligand binding.
  • Further experiments are needed to experimentally differentiate between the 'prism' and 'monkey saddle' models.